Term ends Mar 6, 2034 · High confidence
20-year base term ends Jul 11, 2032
Held by Regeneron Pharmaceuticals, Inc.
Filed Jul 11, 2012 as application 13/546,575 · Granted Jan 19, 2016
Base term plus 603 days of patent term adjustment (USPTO delay)
Today
2012
2034
Clock starts
Jul 11, 2012
Jul 11, 2012
Term ends
Mar 6, 2034
Mar 6, 2034
Granted
Jan 19, 2016
Jan 19, 2016
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
603
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 603 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 11, 2012, when this application, 13/546,575, was filed | Jul 11, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +603 days, USPTO patent term adjustment record | Mar 6, 2034 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 6, 2034 | High confidence |
This family
| US 9,239,332 | this patent Mar 2034 | Mar 2034 |
| US 10,221,214 | In force Jul 2032 | Jul 2032 |
| US 12,480,950 | In force Jan 2036 | Jan 2036 |
| Application 18/969,228 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 16, 2012 Reel 29137, frame 51 | Heath, James R.; Nag, Arundhati; Das, Samir; Deyle, Kaycie M.; Millward, Steven Wesley; Kearney, Paul | Integrated Diagnostics, Inc. | Assignment of Assignor's Interest |
| Feb 14, 2013 Reel 29810, frame 489 | California Institute of Technology | National Institutes of Health (Nih), U.S. Dept. of Health and Human Services (DHHS), U.S. Government | Confirmatory License |
| Sep 5, 2013 Reel 31144, frame 259 | Integrated Diagnostics, Inc. | Indi Molecular, Inc. | Assignment of Assignor's Interest |
| Nov 3, 2017 Reel 44027, frame 632 | Indi Molecular, Inc. | California Institute of Technology | Assignment of Assignor's Interest |
| Nov 2, 2023 Reel 65436, frame 27 | Indi Molecular, Inc. | Regeneron Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2034
Term ends Mar 6, 2034. Maintenance fees still fall due before then
Note
The 603 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
21
later US patents cite this one
That is top 25% of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.